Key result
Early debriefing and enhanced education evaluated to improve post-VTE apixaban adherence.
Why the study?
Although direct oral anticoagulants have simplified VTE management and reduced bleeding risk, the lack of routine laboratory monitoring makes adherence difficult to assess and challenges traditional educational models.
Does early debriefing and enhanced educative components improve apixaban adherence in patients with venous thromboembolism (VTE)?
Does early debriefing and enhanced educative components improve apixaban adherence in patients with venous thromboembolism (VTE)?
Answers are grounded in this paper and cite their sources.
Challenges traditional adherence assessment in VTE; leaves open need for novel monitoring strategies in DOAC education.
Direct oral anticoagulants have improved the management of venous thromboembolism (VTE) by reducing bleeding risk and simplifying treatment, but the absence of routine laboratory monitoring makes treatment adherence difficult to assess and challenges traditional educational models.
No takes yet. Share an insight, caveat, or question.
Couturaud et al. (2026) studied this question. Early debriefing and enhanced educative components were evaluated for their impact on apixaban adherence after venous thromboembolism, as lack of routine DOAC monitoring challenges assessment.
Synapse has enriched 10 related papers. Consider them for comparative context: